Company intelligence / Profile preview

Mcule

Budapest, Budapest, Hungarymcule.com ↗

Ownership: Private
Development stage: Commercial

Overview

Mcule offers an integrated online drug discovery platform that enables scientists in pharma, biotech, and academia to identify hits and leads through virtual screening of over 5 million purchasable compounds. The system includes molecular modeling tools for hit identification and lead optimization as well as automated compound sourcing with price optimization. It supports rapid early-stage drug discovery but does not itself conduct clinical trials or have clinical results.

Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

ChemaxonAtomwiseOpenEye ScientificCortex DiscoveryWuXi TIDES/WuXi AppTec

Beyond the preview

Go deeper on Mcule.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mcule.

Explore the full profile